Inventor · disambiguated record
Satoru Nakai
Also filed as: NAKAI SATORU
28 granted patents·348 citations·filing 1984–1998
97Inventor score
Top patents by PatentIndex Score
28 records- 0190US5360716AHuman tumor necrosis factor αspecific monoclonal antibody and method for detecting human tumor necrosis factor αOTSUKA PHARMA CO LTD·Filed 1993·Granted Nov 1, 1994·136 cites·3 claims
- 0286US5464833AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1993·Granted Nov 7, 1995·33 cites·6 claims
- 0368US5837230AMethods of treating allergies with M-CSFOTSUKA PHARMA CO LTD·Filed 1995·Granted Nov 17, 1998·15 cites·8 claims
- 0468US4898818AAntitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganismOTSUKA PHARMA CO LTD·Filed 1985·Granted Feb 6, 1990·22 cites·2 claims
- 0567US5672603AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1995·Granted Sep 30, 1997·20 cites·6 claims
- 0665US5008374AIL-1α derivatives and drugsOTSUKA PHARMA CO LTD·Filed 1987·Granted Apr 16, 1991·8 cites·8 claims
- 0762US5342615AMethod for treating arthritis or inflammation with Il-1α or derivatives thereofOTSUKA PHARMA CO LTD·Filed 1990·Granted Aug 30, 1994·10 cites·6 claims
- 0860US5723117AUse of interleukin-1 (IL-1) to inhibit development of hepatitisOTSUKA PHARMA CO LTD·Filed 1993·Granted Mar 3, 1998·20 cites·8 claims
- 0955US5543140AMethod and use of IL-1αOTSUKA PHARMA CO LTD·Filed 1994·Granted Aug 6, 1996·7 cites·4 claims
- 1054US5702698AMethods of use of IL-1αOTSUKA PHARMA CO LTD·Filed 1995·Granted Dec 30, 1997·8 cites·1 claims
- 1154US4675291AHuman cultured cell lineOTSUKA PHARMA CO LTD·Filed 1984·Granted Jun 23, 1987·12 cites·4 claims
- 1251US5849282AMethod of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1βOTSUKA PHARMA CO LTD·Filed 1993·Granted Dec 15, 1998·17 cites·2 claims
- 1349US5650297ADNA encoding human colony-stimulating factorsOTSUKA PHARMA CO LTD·Filed 1994·Granted Jul 22, 1997·11 cites·4 claims
- 1448US5120534AIL-1α derivatives and medicament for treating thrombocytopeniaOTSUKA PHARMA CO LTD·Filed 1989·Granted Jun 9, 1992·6 cites·6 claims
- 1540US5371204AGene that encodes for polypeptides of IL-1αOTSUKA PHARMA CO LTD·Filed 1991·Granted Dec 6, 1994·2 cites·5 claims
- 1639US5342614AMethod of treating arthritus or inflammation with IL-1β or derivatives thereofOTSUKA PHARMA CO LTD·Filed 1990·Granted Aug 30, 1994·5 cites·3 claims
- 1737US5925640AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Jul 20, 1999·2 cites·1 claims
- 1837US5691341AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1995·Granted Nov 25, 1997·1 cites·16 claims
- 1936US5847098ADNA encoding interleukin IL-1β mutantOTSUKA PHARMA CO LTD·Filed 1995·Granted Dec 8, 1998·3 cites·5 claims
- 2034US5872120AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Feb 16, 1999·1 cites·1 claims
- 2134US5798358AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Aug 25, 1998·1 cites·1 claims
- 2233US6030839AMethod for determining sodium concentration in alcoholJAPAN NUCLEAR CYCLE DEV INST·Filed 1998·Granted Feb 29, 2000·4 cites·1 claims
- 2333US5543412AHepatitis treatment with carbostyril compoundsOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 6, 1996·1 cites·1 claims
- 2431US5916890AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Jun 29, 1999·0 cites·1 claims
- 2530US6107465AIL-1β and derivatives thereof and drugsOTSUKA PHARMA CO LTD·Filed 1987·Granted Aug 22, 2000·3 cites·40 claims
- 2630US5750529AApoptosis regulating compostionOTSUKA PHARMA CO LTD·Filed 1995·Granted May 12, 1998·0 cites·2 claims
- 2730US5658912AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 19, 1997·0 cites·3 claims
- 2828US5756675AIL-1α derivativesOTSUKA PHARMA CO LTD·Filed 1994·Granted May 26, 1998·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Satoru Nakai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →